2024-09-19 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, consumables, software, and services for research, analysis, diagnostics, and production.

**Performance Analysis:**

1. **Return vs. S&P 500:**
    - **Cumulative Return:** TMO: 250.02%, VOO: 129.06%
    - **Outperformance:** TMO has significantly outperformed the S&P 500, with a difference of 120.96% in cumulative returns. 
    - **Relative Outperformance:** This outperformance is at the 55.73 percentile of historical performance, suggesting that TMO has consistently performed well compared to the broader market.

2. **Recent Price Action:**
    - **Closing Price:** $610.57
    - **Moving Averages:** 
        - 5-day: $613.70
        - 20-day: $612.01
        - 60-day: $585.85
    - **Analysis:** The stock is currently trading slightly below its 5-day and 20-day moving averages, indicating a potential short-term correction. However, the price remains above the 60-day moving average, which suggests an overall positive trend.

3. **Technical Indicators:**
    - **RSI:** 50.13 (Neutral)
    - **PPO:** -0.23 (Slightly Bearish)
    - **Delta_Previous_Relative_Divergence:** 0.16 (Short-term Downward)
    - **Expected_Return:** 97.48% (Max 5-year expected return)
    - **Analysis:** The RSI indicates neutral momentum, while the PPO suggests a slight bearish bias. The relative divergence suggests a recent downward trend. However, the expected return remains high, indicating potential future growth.

4. **Recent Earnings and Forecast:**
    - **Earnings Summary:**
        | Date | EPS | Revenue |
        |---|---|---|
        | 2024-08-02 | 4.05 | $10.54 B |
        | 2024-05-03 | 3.47 | $10.35 B |
        | 2023-11-03 | 4.44 | $10.57 B |
        | 2023-08-04 | 3.53 | $10.69 B |
        | 2024-08-02 | 3.53 | $10.69 B |
    - **Analysis:** Thermo Fisher Scientific Inc. has consistently exceeded revenue expectations in recent quarters. The latest earnings release showed a strong performance, exceeding analyst estimates for both EPS and revenue. This suggests a positive outlook for the company's future.

**Overall Analysis:**

Thermo Fisher Scientific Inc. (TMO) exhibits strong long-term growth potential, evidenced by its significant outperformance against the S&P 500. While recent technical indicators suggest a potential short-term correction, the positive earnings momentum and high expected return support a bullish outlook. The company's robust financial performance and growth prospects make TMO a potentially attractive investment opportunity.